Global Anti-Infective Vaccines Market Forecast 2021-2031: – Market Segment by Product Type (Live/Attenuated Vaccines, Inactivated Vaccines, DNA & Recombination Vector Vaccines, Others), Market Segment by Disease Type {Bacterial Diseases (Typhoid Vaccines, Tuberculosis Vaccines, Tetanus & Diphtheria Vaccines, Others), Viral Diseases (Influenza Vaccines, Hepatitis Vaccines, Polio Vaccines, Others)}, Market Segment by Distribution Channel (Hospitals, Clinics, Others), Plus analysis of leading regional/national markets and leading companies in the market. COVID-19 Impact Recovery Analysis (V-shaped recovery, W-shaped recovery, U-shaped recovery, L-shaped recovery)
Global Anti-Infective Vaccines Market Outlook
According to Visiongain’s lead analyst: ‘The global anti-infective vaccines market was valued at US$49.29 billion in 2020. The global market is expected to reach US$94.08 billion in 2026 from its previous value of US$54.26 billion in 2021. Visiongain further anticipates that the worldwide anti-infective vaccines market will reach US$187.26 billion in 2031’.
Download Exclusive Sample Report @ https://www.visiongain.com/report/anti-infective-vaccines-market-2021/#download_sampe_div
Key Questions Answered by this Report:
- What is the current size of the overall global anti-infective vaccines market? How much will this market be worth from 2021 to 2031?
- What are the main drivers and restraints that will shape the overall anti-infective vaccines market over the…
